Skip to content

Clinical trials

Phase 2 Sepsis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Phase: Phase 2 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20081
20101
20141
20171
20191
20202
20221
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Novartis Pharmaceuticals2
AM-Pharma1
Agennix1
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier de Meaux1
Eli Lilly and Company1
Enlivex Therapeutics Ltd.1
GlaxoSmithKline1
Inotrem1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis14
Acute Kidney Injury4
Shock, Septic4
COVID-191
Cholecystitis, Acute1
Community-Acquired Pneumonia1
Intraabdominal Infections1
Lymphopenia1
Shock1
Stroke1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.